Traditional Chinese medicine composition, traditional Chinese medicine extract and application of traditional Chinese medicine composition and traditional Chinese medicine extract in preparation of medicine for treating pain

By using traditional Chinese medicine compositions such as Chuanwu, Naoyanghua, Xu Changqing, Rhubarb and Huangbai, combined with HPLC technology and permeation method, the extraction process is optimized, and the problems of poor permeability and poor treatment effect of traditional Chinese medicine gels are solved, and safe and efficient are prepared The Chinese medicine extract is used for pain treatment and meets the clinical safety and effectiveness requirements of analgesic drugs.

CN119033858AActive Publication Date: 2024-11-29GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411031260.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-29
Estimated Expiration
2044-07-30

AI Technical Summary

Technical Problem

The existing traditional Chinese medicine gels have poor permeability and poor treatment effect in pain treatment, and the preparation process is unreasonable, which is prone to allergic reactions, making it difficult to meet the clinical safety and effectiveness requirements for analgesic drugs.

Method used

Using traditional Chinese medicine compositions such as Chuanwu, Naoyanghua, Xu Changqing, Rhubarb and Huangbai, combined with high performance liquid chromatography (HPLC) technology and permeation method, the extraction process is optimized to prepare traditional Chinese medicine extracts with good permeability and safety. Used to prepare topical medications for the treatment of pain.

Benefits of technology

A traditional Chinese medicine gel with significantly improved analgesic effect, strong skin permeability and high safety has been achieved, meeting the needs of clinical medicine, reducing side effects, and improving the effect of pain treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119033858A_ABST
    Figure CN119033858A_ABST
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition, a traditional Chinese medicine extract and application of the traditional Chinese medicine composition and the traditional Chinese medicine extract in preparation of a medicine for treating pain. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 4-8 parts of radix aconiti, 14-18 parts of flos rhododendri mollis, 20-24 parts of radix cynanchi paniculati, 20-24 parts of radix et rhizoma rhei and 14-18 parts of cortex phellodendri. The invention provides a novel traditional Chinese medicine formula for pain treatment and an external traditional Chinese medicine preparation prepared on the basis of the traditional Chinese medicine formula, which have excellent effects of good analgesic effect, strong skin permeability and good safety, are convenient to use and meet clinical medication requirements.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the pharmaceutical field, and in particular to a Chinese medicine composition, a Chinese medicine extract and application thereof in preparing medicine for treating pain. Background Art

[0002] Pain is a complex process in which the body is stimulated by harmful stimuli and acts on pain receptors, which then transmit pain signals to the central nervous system through primary afferent fibers. Many diseases can cause pain clinically, such as traumatic injuries, rheumatism or rheumatoid arthritis, cancer, etc., which affect patients' work and reduce their quality of life. At present, the clinical treatment of pain mainly uses Western medicines such as opioids or non-steroidal anti-inflammatory drugs, but long-term use is often accompanied by many side effects, causing damage to the gastrointestinal tract, skin, cardiovascular, liver and kidneys, and even causing dependence and addiction. Therefore, the development of analgesics with low addiction and few adverse reactions has important clinical value.

[0003] In terms of pain treatment, Chinese medicine has attracted more and more researchers' attention with its unique pharmacological effects and overall regulatory advantages. As a form of Chinese medicine preparation, Chinese medicine gel has the characteristics of easy use, direct action, and small side effects, and is particularly suitable for the treatment of skin and soft tissue pain. However, the Chinese medicine gel currently on the market still has certain limitations in pain treatment. Some gels have poor permeability, are difficult to reach deep tissues, and have poor therapeutic effects. The unreasonable preparation process causes unstable drug efficacy and is prone to adverse reactions such as allergies. Therefore, the development of external Chinese medicine gels with good analgesic effect, strong permeability and high safety is of great significance for improving the effect of pain treatment. Summary of the invention

[0004] In order to solve the above problems existing in the prior art, the present invention provides a Chinese medicine composition, a Chinese medicine extract and its application in the preparation of medicine for treating pain by combining the pharmacological effects of Chinese medicine with modern preparation technology.

[0005] The first object of the present invention is to provide a traditional Chinese medicine composition.

[0006] The second object of the present invention is to provide a Chinese medicine extract.

[0007] The third object of the present invention is to provide the use of the Chinese medicine composition and / or the Chinese medicine extract in the preparation of a product for treating pain.

[0008] The fourth object of the present invention is to provide an external medicine for treating pain.

[0009] A fifth object of the present invention is to provide a method for preparing an external medicine for treating pain.

[0010] In order to achieve the above object, the present invention is implemented by the following scheme:

[0011] Chuanwu, pungent, bitter, hot in nature, has the effects of dispelling wind and dampness, warming the meridians and relieving pain, and is mainly used for wind-cold dampness arthralgia, joint pain, cold pain in the heart and abdomen, cold hernia pain and anesthesia and pain relief; Dahuanghua, pungent, warm, highly toxic, has the effects of dispelling wind and dampness, relaxing muscles and activating blood circulation, relieving pain and pain, and is often used to treat rheumatism, fracture pain, toothache, and skin stubborn ringworm; Xuchangqing, pungent, warm, has the effects of dispelling wind and cold, removing dampness and relieving pain, and is often used for rheumatism, back pain, pain caused by injuries, abdominal pain, toothache and other pain syndromes; Dahuang, bitter, cold in nature, has the effects of purging and guiding stagnation, purging fire and cooling blood, promoting blood stasis and breaking up accumulation, clearing away heat and detoxifying, and treats abdominal pain caused by accumulation, damp-heat diarrhea, accumulation of masses, injuries and other symptoms; Huangbai, bitter, cold in nature. It has the effects of clearing heat and dampness, purging fire and removing steaming, detoxifying and treating sores, and is mainly used to treat sores, swelling and poison, eczema and wet sores. The present invention uses the above-mentioned medicines in combination, has the effects of warming the meridians and relieving pain, dispelling wind and dampness, cooling blood and detoxifying, and is used for external treatment of pain with good curative effect.

[0012] A traditional Chinese medicine composition is prepared from the following components: by weight, 4-8 parts of Chuanwu, 14-18 parts of Dahurian Wolf, 20-24 parts of Cynanchum chinense, 20-24 parts of Rhubarb and 14-18 parts of Phellodendron amurense.

[0013] Preferably, the components used to make the traditional Chinese medicine composition further include: 10 to 12 parts of Glauber's salt, by weight.

[0014] More preferably, the components used to make the traditional Chinese medicine composition further include, by weight: 2 to 4 parts of borneol.

[0015] Further preferably, the Chinese medicine composition is made of the following components: by weight, 6.8 parts of Chuanwu, 16.8 parts of Dahurian Wolf, 22.5 parts of Cynanchum wilfordii, 22.5 parts of Rhubarb, 16.8 parts of Phellodendron amurense, 11.2 parts of Sodium Sulfate, and 3.4 parts of Borneol.

[0016] Further preferably, the Chinese medicine composition is made of the following components: by weight, 4 parts of Chuanwu, 14 parts of Dahurian Wolff, 20 parts of Cynanchum wilfordii, 20 parts of Rhubarb, 14 parts of Phellodendron amurense, 10 parts of Sodium Sulfate and 2 parts of Borneol.

[0017] Further preferably, the Chinese medicine composition is made of the following components: by weight, 8 parts of Chuanwu, 18 parts of Dahurian Wolff, 24 parts of Cynanchum wilfordii, 24 parts of Rhubarb, 18 parts of Phellodendron amurense, 12 parts of Sodium Sulfate and 4 parts of Borneol.

[0018] The use of any of the above-mentioned Chinese medicine compositions in the preparation of products for treating pain should also be within the protection scope of the present invention.

[0019] A Chinese medicine extract is a water extract and / or an alcohol extract of a Chinese medicine composition. The Chinese medicine composition is prepared from the following components: by weight, 4 to 8 parts of Chuanwu, 14 to 18 parts of Dahurian Wolfberry, 20 to 24 parts of Cynanchum wilfordii, 20 to 24 parts of Rhubarb and 14 to 18 parts of Phellodendron amurense.

[0020] Preferably, the components used to make the traditional Chinese medicine composition further include: 10 to 12 parts of Glauber's salt, by weight.

[0021] More preferably, the components used to make the traditional Chinese medicine composition further include, by weight: 2 to 4 parts of borneol.

[0022] Further preferably, the Chinese medicine composition is made of the following components: by weight, 6.8 parts of Chuanwu, 16.8 parts of Dahurian Wolf, 22.5 parts of Cynanchum wilfordii, 22.5 parts of Rhubarb, 16.8 parts of Phellodendron amurense, 11.2 parts of Sodium Sulfate, and 3.4 parts of Borneol.

[0023] Further preferably, the Chinese medicine composition is made of the following components: by weight, 4 parts of Chuanwu, 14 parts of Dahurian Wolff, 20 parts of Cynanchum wilfordii, 20 parts of Rhubarb, 14 parts of Phellodendron amurense, 10 parts of Sodium Sulfate and 2 parts of Borneol.

[0024] Further preferably, the Chinese medicine composition is made of the following components: by weight, 8 parts of Chuanwu, 18 parts of Dahurian Wolff, 24 parts of Cynanchum wilfordii, 24 parts of Rhubarb, 18 parts of Phellodendron amurense, 12 parts of Sodium Sulfate and 4 parts of Borneol.

[0025] Preferably, the Chinese medicine extract is a water extract and an alcohol extract of the Chinese medicine composition.

[0026] Different extraction process routes have a great impact on the retention of efficacy and effective substances. Traditional Chinese medicine compound medicines have many components, complex ingredients, and weak basic research on effective substances, which poses a challenge to pre-treatment of preparations. In order to avoid the problem of low sensitivity and inability to determine the quality of the process when optimizing the extraction process route based solely on pharmacodynamic indicators, the present invention combines high performance liquid chromatography (HPLC) characteristic spectrum detection technology and multiple indicator component retention rates to evaluate and determine the extraction process route, and the results are more sensitive and reliable.

[0027] Preferably, the method for preparing the Chinese herbal medicine extract comprises decoction and / or percolation.

[0028] More preferably, the decoction method comprises the following steps: fully decocting the Chinese medicine composition with water, separating the solid from the liquid, and collecting the liquid.

[0029] Further preferably, the decoction method comprises the following steps: firstly decoct the Chuanwu with water, and then fully decoct the decoction with the Dahurian Wolf, the Cynanchum chinense, the Rhubarb and the Phellodendron amurense, separate the solid and liquid, and collect the liquid.

[0030] Further preferably, the decoction method comprises the following steps: firstly decoct the Chuanwu with water in an amount of 6 to 9 times the volume of the weight of the Chuanwu for 1 to 3 hours, and then fully decoct the decoction with the Dahurian Wolf, the Cynanchum cyrtonema, the Rhubarb and the Phellodendron amurense and water in an amount of 6 to 20 times the volume of the total weight of the medicinal materials, separate the solid and liquid, and collect the liquid.

[0031] Still further preferably, the decoction method comprises the following steps: firstly decoct the Chuanwu with water in an amount of 6 to 8 times the volume of the weight of the Chuanwu for 1 to 2 hours, and then combine the decoction with the Dahurian Wolf, the Cynanchum wilfordii, the Rhubarb and the Phellodendron amurense, and decoct in 2 times, with the amount of water added each time being 6 to 8 times the volume of the total weight of the medicinal materials, and decoct for 1 to 2 hours each time, filter, and combine the filtrate.

[0032] Specifically, the decoction method includes the following steps: weighing Chuanwu decoction pieces, Dahuanghua decoction pieces, Xu Changqing decoction pieces, Dahuang decoction pieces and Huangbai decoction pieces; decocting Chuanwu for 2 hours and then adding water for decocting three times, with the amount of water added being 8, 6 and 6 times the volume of the total weight of the medicinal materials respectively, decocting three times in total, each time for 1 hour, filtering and combining the filtrate.

[0033] More preferably, the percolation method comprises the following steps: soaking the Chinese medicine composition, fully percolating with a solvent, and collecting the percolation liquid.

[0034] Further preferably, the Chinese medicine composition is in the form of fine powder, medium powder or coarse powder.

[0035] More preferably, the Chinese medicine composition is Chinese medicine powder.

[0036] More preferably, the immersion time is 0 h to 24 h.

[0037] More preferably, the immersion time is 0 h.

[0038] More preferably, the amount of the solvent used is 3 to 9 times the volume of the total weight of the medicinal materials.

[0039] More preferably, the amount of the solvent used is 4 to 8 times the volume of the total weight of the medicinal materials.

[0040] Still more preferably, the amount of the solvent used is 6 times the volume of the total weight of the medicinal materials.

[0041] More preferably, the solvent is ethanol.

[0042] More preferably, the solvent is 30 v / v% to 90 v / v% ethanol.

[0043] Still more preferably, the solvent is 40 v / v% to 80 v / v% ethanol.

[0044] Most preferably, the solvent is 80 v / v% ethanol.

[0045] More preferably, the percolation rate is 3 ml / min / kg to 9 ml / min / kg.

[0046] More preferably, the percolation rate is 9 ml / min / kg.

[0047] Specifically, the method for preparing the Chinese medicine extract by percolation includes the following steps: weighing the powder of Chuanwu, the powder of Dahurian dwarf angelica, the powder of Cynanchum wilfordii, the powder of Rhubarb and the powder of Phellodendron chinense according to the prescription amount; percolating with 80v / v% ethanol in an amount of 6 times the volume of the total weight of the medicinal materials at a speed of 9ml / min / kg, and collecting the percolation liquid.

[0048] The use of any of the above-mentioned Chinese herbal extracts in the preparation of products for treating pain should also be within the protection scope of the present invention.

[0049] A topical medicine for treating pain, comprising a Chinese medicine composition and / or a Chinese medicine extract; the Chinese medicine composition is prepared from the following components: by weight, 4-8 parts of Chuanwuji, 14-18 parts of Dahurian Wolff, 20-24 parts of Cynanchum wilfordii, 20-24 parts of Rhubarb and 14-18 parts of Phellodendron chinense; the Chinese medicine extract is a water extract and / or an alcohol extract of the Chinese medicine composition.

[0050] Preferably, the components used to make the traditional Chinese medicine composition further include: 10 to 12 parts of Glauber's salt, by weight.

[0051] Preferably, the Chinese medicine extract is a water extract and an alcohol extract of the Chinese medicine composition.

[0052] Preferably, the method for preparing the Chinese herbal medicine extract comprises decoction and / or percolation.

[0053] More preferably, the decoction method comprises the following steps: fully decocting the Chuanwu, the Dahurian Wolf, the Cynanchum wilfordii, the Rhubarb and the Phellodendron amurense with water, separating the solid and the liquid, and collecting the liquid.

[0054] Further preferably, the decoction method comprises the following steps: firstly decoct the Chuanwu with water, and then fully decoct the decoction with the Dahurian Wolf, the Cynanchum chinense, the Rhubarb and the Phellodendron amurense, separate the solid and liquid, and collect the liquid.

[0055] More preferably, the decoction method comprises the following steps: firstly decoct the Chuanwu with 6 to 9 times the amount of water for 1 to 3 hours, and then fully decoct the decoction with the Dahurian Wolf, the Cynanchum wilfordii, the Rhubarb and the Phellodendron amurense and 4 to 8 times the amount of water, separate the solid and liquid, and collect the liquid.

[0056] Still further preferably, the decoction method comprises the following steps: firstly decoct the Chuanwu with 6 to 8 times the amount of water for 1 to 2 hours, then combine the decoction with the Dahurian Wolf, the Cynanchum wilfordii, the Rhubarb and the Phellodendron amurense and continue to decoct for 1 to 2 hours, then decoct twice with 6 to 8 times the amount of water, each time for 1 to 2 hours, filter, and combine the filtrate.

[0057] Specifically, the decoction method includes the following steps: weighing Chuanwu slices, Dahurian hyssop slices, Cynanchum paniculatum slices, Rhubarb slices and Phellodendron chinense slices; first decocting the Chuanwu slices with 8 times the volume of water of the above five medicinal materials for 2 hours, then combining the decoction with the Dahurian hyssop slices, Cynanchum paniculatum slices, Rhubarb slices and Phellodendron chinense slices, and decocting with 8 times the volume of water, 6 times the volume of water and 6 times the volume of water in turn, each time for 1 hour, filtering and combining the filtrate.

[0058] More preferably, the percolation method comprises the following steps: soaking the Chinese medicine composition, fully percolating with a solvent, and collecting the percolation liquid.

[0059] Further preferably, the Chinese medicine composition is in the form of fine powder, medium powder or coarse powder.

[0060] More preferably, the Chinese medicine composition is Chinese medicine powder.

[0061] More preferably, the immersion time is 0 h to 24 h.

[0062] More preferably, the immersion time is 0 h.

[0063] More preferably, the amount of the solvent is 3 to 9 times the amount.

[0064] More preferably, the amount of the solvent is 4 to 8 times the amount.

[0065] Still more preferably, the amount of the solvent used is 6 times the amount.

[0066] More preferably, the solvent is ethanol.

[0067] More preferably, the solvent is 30 v / v% to 90 v / v% ethanol.

[0068] Still more preferably, the solvent is 40 v / v% to 80 v / v% ethanol.

[0069] Most preferably, the solvent is 80 v / v% ethanol.

[0070] More preferably, the percolation rate is 3 ml / min / kg to 9 ml / min / kg.

[0071] More preferably, the percolation rate is 9 ml / min / kg.

[0072] Specifically, the method for preparing the Chinese medicine extract by percolation includes the following steps: weighing the powder of Chuanwu, the powder of Dahurian ash, the powder of Cynanchum wilfordii, the powder of Rhubarb and the powder of Phellodendron chinense according to the prescription amount; percolating with 6 times the amount of 80v / v% ethanol at a speed of 9ml / min / kg, and collecting the percolation liquid.

[0073] Preferably, the topical drug is a semisolid preparation or a liquid preparation. The liquid preparation includes but is not limited to paints, pour-ons, lotions, tinctures and liniments. The semisolid preparation includes but is not limited to ointments, creams, pastes, eye ointments, gels and suppositories.

[0074] More preferably, the liquid preparation is a tincture or a liniment.

[0075] More preferably, the semisolid preparation is a gel.

[0076] The matrix is ​​not only the excipient of the gel, but also has an important influence on the quality and therapeutic effect of the gel.

[0077] More preferably, the matrix of the semisolid preparation is a water-soluble matrix.

[0078] More preferably, the water-soluble matrix is ​​hydroxyethyl cellulose.

[0079] More preferably, the final concentration of the hydroxyethyl cellulose is 0.5 wt % to 2 wt %.

[0080] Still more preferably, the final concentration of the hydroxyethyl cellulose is 1.5 wt %.

[0081] More preferably, the semisolid preparation is a transdermal penetration enhancer.

[0082] More preferably, the transdermal penetration enhancer is any one of azone, oleic acid, isopropyl myristate and propylene glycol.

[0083] More preferably, the transdermal penetration enhancer is propylene glycol.

[0084] Still more preferably, the final concentration of the propylene glycol is 2 wt % to 7 wt %.

[0085] Most preferably, the final concentration of propylene glycol is 5 wt%.

[0086] A method for preparing an external medicine for treating pain, comprising the following steps:

[0087] S1. A Chinese medicine composition treated by decoction or percolation; the Chinese medicine composition is made of the following components: by weight, 4 to 8 parts of Chuanwu, 14 to 18 parts of Dahuanghua, 20 to 24 parts of Cynanchum, 20 to 24 parts of Rhubarb and 14 to 18 parts of Phellodendron;

[0088] S2. Fully mix the product obtained in step S1 with the sodium sulfate and borneol to obtain the product; the amount of the crude drug per 1 g or 1 ml of the product obtained in step S1 is 0.1 g / ml to 1.5 g / ml.

[0089] Preferably, in step S1, the components for making the traditional Chinese medicine composition further include, by weight: 10 to 12 parts of Glauber's salt.

[0090] More preferably, in step S1, the components for making the traditional Chinese medicine composition further include: 2 to 4 parts of borneol, by weight.

[0091] Further preferably, in step S1, the Chinese medicine composition is made of the following components: in parts by weight, 6.8 parts of Chuanwu, 16.8 parts of Dahurian Wolf, 22.5 parts of Cynanchum wilfordii, 22.5 parts of Rhubarb, 16.8 parts of Phellodendron amurense, 11.2 parts of Sodium Sulfate, and 3.4 parts of Borneol.

[0092] Further preferably, in step S1, the Chinese medicine composition is made of the following components: in parts by weight, 4 parts of Chuanwu, 14 parts of Dahurian Wolff, 20 parts of Cynanchum wilfordii, 20 parts of Rhubarb, 14 parts of Phellodendron amurense, 10 parts of Sodium Sulfate and 2 parts of Borneol.

[0093] Further preferably, in step S1, the Chinese medicine composition is made of the following components: in parts by weight, 8 parts of Chuanwu, 18 parts of Dahurian Wolff, 24 parts of Cynanchum wilfordii, 24 parts of Rhubarb, 18 parts of Phellodendron amurense, 12 parts of Sodium sulfate and 4 parts of Borneol.

[0094] Preferably, in step S1, the decoction method comprises the following steps: fully decocting the traditional Chinese medicine composition with water, separating the solid from the liquid, and collecting the liquid.

[0095] More preferably, in step S1, the decoction method comprises the following steps: firstly decoct the Chuanwu with water, and then fully decoct the decoction with the Dahurian Wolf, the Cynanchum chinense, the Rhubarb and the Phellodendron amurense, separate the solid and liquid, and collect the liquid.

[0096] Further preferably, in step S1, the decoction method includes the following steps: first, decoct the Chuanwu for 1 to 3 hours with water in an amount 6 to 9 times the weight of the five medicinal materials of Chuanwu, Dawu, Cynanchum, Rhubarb, and Phellodendron, and then fully decoct the decoction with water in an amount 6 to 20 times the volume of the Dawu, Cynanchum, Rhubarb, and Phellodendron as well as the total weight of the medicinal materials, separate the solid and liquid, and collect the liquid.

[0097] Further preferably, in step S1, the decoction method comprises the following steps: first, decoct the Chuanwu with water in an amount of 6 to 8 times the total weight of the five medicinal materials, namely, Chuanwu, Dahuang, and Phellodendron, for 1 to 2 hours; then, combine the decoction with the Dahuang, Dahuang, and Phellodendron, and decoct in 2 times, with the amount of water added each time being 6 to 8 times the volume of the total weight of the five medicinal materials; decoct for 1 to 2 hours each time; filter, and combine the filtrate.

[0098] Specifically, in step S1, the decoction method includes the following steps: weighing Chuanwu decoction pieces, Dahuang decoction pieces, Xu Changqing decoction pieces, Dahuang decoction pieces and Huangbai decoction pieces; first decocting the Chuanwu for 2 hours with water in an amount 8 times the volume of the total weight of the five medicinal materials, Dahuang, Xu Changqing, Dahuang and Huangbai, adding water for decoction three times, the amount of water added being 8, 6 and 6 times the volume of the total weight of the five medicinal materials respectively, decocting three times in total, each time for 1 hour, filtering, and combining the filtrate.

[0099] Preferably, in step S1, the percolation method comprises the following steps: soaking the traditional Chinese medicine composition, fully percolating with a solvent, and collecting the percolation liquid.

[0100] More preferably, in step S1, the Chinese medicine composition is a fine powder, a medium powder or a coarse powder.

[0101] Further preferably, in step S1, the Chinese medicine composition is Chinese powder.

[0102] More preferably, in step S1, the immersion time is 0 h to 24 h.

[0103] Still more preferably, in step S1, the immersion time is 0 h.

[0104] More preferably, in step S1, the amount of the solvent used is 3 to 9 times the volume of the total weight of the medicinal materials.

[0105] Further preferably, in step S1, the amount of the solvent used is 4 to 8 times the volume of the total weight of the medicinal materials.

[0106] More preferably, in step S1, the amount of the solvent used is 6 times the volume of the total weight of the medicinal materials.

[0107] More preferably, in step S1, the solvent is ethanol.

[0108] Further preferably, in step S1, the solvent is 30 v / v% to 90 v / v% ethanol.

[0109] More preferably, in step S1, the solvent is 40 v / v% to 80 v / v% ethanol.

[0110] Still more preferably, in step S1, the solvent is 80 v / v% ethanol.

[0111] More preferably, in step S1, the percolation rate is 3 ml / min / kg to 9 ml / min / kg.

[0112] Further preferably, in step S1, the percolation rate is 9 ml / min / kg.

[0113] Specifically, in step S1, the method for preparing the Chinese medicine extract by percolation includes the following steps: weighing the Chinese powder of Aconiti Lateralis Preparata, the Chinese powder of Rhizoma Schisandrae Chinensis, the Chinese powder of Rheum officinale, and the Chinese powder of Phellodendron chinense according to the prescription amount; percolating with 80v / v% ethanol in an amount of 6 times the volume of the total weight of the medicinal materials at a speed of 9ml / min / kg, and collecting the percolation liquid.

[0114] Preferably, in step S2, thenardite and borneol are fully mixed with the filtered product obtained in step S1.

[0115] More preferably, in step S2, the amount of the crude drug per 1 g or 1 ml of the product obtained in step S1 is 0.1 g / ml to 1.5 g / ml.

[0116] More preferably, in step S2, the method for adjusting the amount of crude drug in the product obtained in step S1 is concentration.

[0117] Further preferably, in step S2, the concentration is concentration under reduced pressure.

[0118] More preferably, in step S2, the temperature of the reduced pressure concentration is 50°C to 80°C.

[0119] Still more preferably, in step S2, the temperature of the reduced pressure concentration is 60°C to 80°C.

[0120] Most preferably, in step S2, the temperature of the reduced pressure concentration is 70°C.

[0121] More preferably, in step S2, the vacuum degree of the reduced pressure concentration is -0.08 MPa to -0.04 MPa.

[0122] Still more preferably, in step S2, the vacuum degree of the reduced pressure concentration is -0.06 MPa.

[0123] More preferably, in step S2, the concentrated product is concentrated under reduced pressure using a rotary evaporator.

[0124] Preferably, the external medicine is a semisolid preparation, and in step S2, the mirabilite is firstly mixed with the product obtained in step S1, and the obtained mixture is then mixed with borneol. The semisolid preparation includes but is not limited to ointments, creams, pastes, eye ointments, gels and suppositories.

[0125] More preferably, the semisolid preparation is a gel.

[0126] More preferably, in step S2, the amount of the crude drug per 1 g or 1 ml of the product obtained in step S1 is 0.25 g / ml to 1.25 g / ml.

[0127] Further preferably, in step S2, the amount of the crude drug per 1 g or 1 ml of the product obtained in step S1 is 1.25 g / ml.

[0128] More preferably, in step S2, the sodium sulfate, the product obtained in step S1 and the substrate are firstly reacted fully until they are completely swollen, and then the obtained reactants are fully mixed with borneol.

[0129] Further preferably, in step S2, the borneol microemulsion is obtained by fully reacting borneol fine powder, propylene glycol, polyoxyethylene 40 hydrogenated castor oil, isopropyl palmitate, 5w / v% ethylparaben ethanol solution and water in the mass volume percentage of (3-4) g: (3-4) ml: (6-7) g: (1-2) ml: (1-2) ml: (3-4) ml.

[0130] More preferably, in step S2, the borneol microemulsion is obtained by fully reacting borneol fine powder, propylene glycol, polyoxyethylene 40 hydrogenated castor oil, isopropyl palmitate and 5w / v% ethylparaben ethanol solution in the mass volume percentage of 3.4g:3.4ml:6.7g:1.1ml:1.1ml:3.5ml.

[0131] Further preferably, in step S2, the matrix is ​​a water-soluble matrix.

[0132] More preferably, in step S2, the water-soluble matrix is ​​hydroxyethyl cellulose.

[0133] Still more preferably, in step S2, the final concentration of the hydroxyethyl cellulose is 0.5 wt % to 2 wt %.

[0134] Most preferably, in step S2, the final concentration of the hydroxyethyl cellulose is 1.5 wt %.

[0135] Further preferably, the external medicine further comprises a transdermal penetration enhancer, and the preparation method further comprises the following steps: S3. fully mixing the product obtained in step S2 with the transdermal penetration enhancer.

[0136] More preferably, in step S3, the transdermal penetration enhancer is any one of azone, oleic acid, isopropyl myristate and propylene glycol.

[0137] Still more preferably, in step S3, the transdermal penetration enhancer is propylene glycol.

[0138] Still more preferably, in step S3, the final concentration of the propylene glycol is 2 wt % to 7 wt %.

[0139] Most preferably, in step S3, the final concentration of propylene glycol is 5 wt %.

[0140] Preferably, the external medicine is a liquid preparation, and in step S1, the Chinese medicine composition is treated by percolation. The liquid preparation includes but is not limited to a coating, a pour-on, a lotion, a tincture and an liniment.

[0141] More preferably, the liquid preparation is a tincture or a liniment.

[0142] More preferably, in step S2, the amount of the crude drug per 1 g or 1 ml of the product obtained in step S1 is 0.1 g / ml to 1.0 g / ml.

[0143] More preferably, in step S2, the borneol is firstly fully mixed with the product obtained in step S1, and then the obtained mixture is fully mixed with the mirabilite.

[0144] Further preferably, in step S2, the borneol fine powder is firstly fully mixed with the product obtained in step S1, and the obtained mixture is then fully mixed with the mirabilite fine powder.

[0145] More preferably, step S2 further comprises: adjusting the alcohol content of the product obtained in step S2 to 40 v / v% to 60 v / v%.

[0146] More preferably, step S2 further comprises: adjusting the alcohol content of the product obtained in step S2 to 50 v / v%.

[0147] Compared with the prior art, the present invention has the following beneficial effects:

[0148] The present invention provides a novel Chinese medicine formula for pain treatment, and a Chinese medicine preparation for external use prepared based on the formula, which has excellent efficacy of good analgesic effect, strong skin permeability and good safety, is easy to use, and meets the needs of clinical medication. BRIEF DESCRIPTION OF THE DRAWINGS

[0149] Figure 1 It is the characteristic spectrum result of HPLC chromatography detection of gel test solution at a wavelength of 254nm, S1 is sample I gel, S2 is sample II gel; Peaks 1, 5, 10, 11, 12, 13 and 14 are the chromatographic peaks of phellodendron hydrochloride, berberine hydrochloride, paeonol, aloe-emodin, rhein, rhein and chrysophanol respectively; Peaks 2, 3, 4, 6, 7, 8 and 9 are the characteristic peaks of unknown compounds.

[0150] Figure 2It is the characteristic spectrum result of HPLC chromatography detection of gel test solution at a wavelength of 284nm, S1 is sample I gel, S2 is sample II gel; Peaks 1, 5, 10, 11, 12, 13 and 14 are the chromatographic peaks of phellodendron hydrochloride, berberine hydrochloride, paeonol, aloe-emodin, rhein, rhein and chrysophanol respectively; Peaks 2, 3, 4, 6, 7, 8 and 9 are the characteristic peaks of unknown compounds.

[0151] Figure 3 These are the appearance pictures of Weikang gel prepared with different matrices; A is based on hydroxyethyl cellulose; B is based on carbomer.

[0152] Figure 4 Transdermal diffusion curves of paeonol in Weikang gel prepared with different penetration enhancers.

[0153] Figure 5 Transdermal diffusion curves of berberine hydrochloride in Weikang gel prepared with different penetration enhancers. DETAILED DESCRIPTION

[0154] The present invention is further described in detail below in conjunction with the accompanying drawings and specific examples of the specification. The examples are only used to explain the present invention and are not used to limit the scope of the present invention. The test methods used in the following examples are conventional methods unless otherwise specified; the materials and reagents used are reagents and materials that can be obtained from commercial channels unless otherwise specified.

[0155] The instruments used in the following examples include: national standard test sieve (Zhejiang Tiantai Feida Metal Sieve Factory), rotary evaporator (N-1100V, Tokyo Rika Instruments Co., Ltd., Japan), and high performance liquid chromatograph (Agilent 1260 Infinity II, Agilent Technologies, USA).

[0156] The reagents used in the following examples include: polyoxyethylene 40 hydrogenated castor oil (RH-40, CAS#: 23593-75-1, BASF GmbH, Germany), isopropyl palmitate (CAS#: 142-91-6, Shanghai Aladdin Biochemical Technology Co., Ltd.), ethylparaben (CAS#: 120-47-8, Tianjin Yongda Chemical Reagent Co., Ltd.), hydroxyethyl cellulose (HEC) (CAS#: 9004-62-0, ASHLAND INDUSTRIES NEDERLAND BV), carbomer-940 (CAS#: 9007-20-9, Shanghai MacLean Biochemical Technology Co., Ltd.), and Voltaren Gel (GSK Consumer Healthcare S.A.).

[0157] The experimental animals used in the following examples are: SPF-grade KM mice, male, weighing 25-30 g, purchased from Zhuhai Baishitong Biotechnology Co., Ltd., experimental animal quality license number: SCXK (Guangdong) 2020-0051.

[0158] Embodiment 1 Weikang gel prescription

[0159] The invention provides a traditional Chinese medicine preparation for analgesia, which is named "Weicon Gel". The prescription of the main effective ingredients is: by weight, 4-8 parts of Chuanwu, 14-18 parts of Dahurian Wolf, 20-24 parts of Cynanchum chinense, 20-24 parts of Rhubarb, 14-18 parts of Phellodendron, 10-12 parts of Sodium Sulfate and 2-4 parts of Borneol.

[0160] The following are 3 specific prescriptions for the establishment of the following Weikang gel extraction process and molding process:

[0161] Prescription 1: by weight, 6.8 parts of Chuanwu, 16.8 parts of Dahurian Wolfberry, 22.5 parts of Cynanchum chinense, 22.5 parts of Rhubarb, 16.8 parts of Phellodendron amurense, 11.2 parts of Sodium Sulfate, and 3.4 parts of Borneol;

[0162] Prescription 2: by weight, 4 parts of Chuanwu, 14 parts of Dahurian Wolfberry, 20 parts of Cynanchum chinense, 20 parts of Rhubarb, 14 parts of Phellodendron amurense, 10 parts of Sodium Sulfate, and 2 parts of Borneol;

[0163] Prescription 3: by weight, 8 parts of Chuanwu, 18 parts of Dahurian Wolfberry, 24 parts of Cynanchum wilfordii, 24 parts of Rhubarb, 18 parts of Phellodendron amurense, 12 parts of Sodium Sulfate, and 4 parts of Borneol.

[0164] Example 2 Establishment of Weikang Gel Extraction Process

[0165] 1. Determination of extraction process route

[0166] The water decoction method and the dilute ethanol percolation method were used to extract Chuanwu, Dahurian Wolf, Cynanchum, Rheum officinale and Phellodendron in the traditional Chinese medicine composition described in Example 1, respectively. The extraction process route was determined by combining the acetic acid writhing test with the HPLC characteristic spectrum and the retention rate of the index components.

[0167] (1) Decoction method

[0168] 1. Weighing of medicinal materials: According to the prescription 1 in Example 1, weigh the prescribed amount of Chuanwu decoction pieces, Dahuanghua decoction pieces, Cynanchum chinense decoction pieces, Rhubarb decoction pieces and Phellodendron decoction pieces.

[0169] 2. Extraction (decocting with water): first decoct Chuanwu with water for 2 hours, and the amount of water added is 8 times the volume of the total weight of the above five medicinal materials. Then, decoct it with Rhizoma Alismatis, Cynanchum wilfordii, Rhubarb and Phellodendron amurense for three times, and the amount of water added is 8, 6 and 6 times the volume of the total weight of the five medicinal materials respectively. Decoction three times in total, each time for 1 hour, filter and combine the medicinal liquids.

[0170] 3. Concentration: Place the obtained medicinal solution on a rotary evaporator, and concentrate under reduced pressure at 60°C and a vacuum degree of -0.06 MPa to obtain an extract with a crude drug content of 1 g / ml.

[0171] 4. Molding: Filter the extract while hot, add the prescribed amount of mirabilite powder (all of which can pass through the No. 5 sieve and contain no less than 95% of which can pass through the No. 6 sieve) and 5.6 g of glycerol to the filtrate to dissolve, add 1.5 g of hydroxyethyl cellulose in small amounts and multiple times, stir quickly and evenly, cool to room temperature, and obtain a high-dose sample I gel (raw drug amount is 1.0 g / g).

[0172] According to the above method, the only difference is that in step 3, the extract with a crude drug amount of 0.5 g / ml is obtained by vacuum concentration, that is, the medium-dose sample I gel (crude drug amount of 0.5 g / g) is prepared; the extract with a crude drug amount of 0.25 g / ml is obtained by vacuum concentration, that is, the low-dose sample I gel (crude drug amount of 0.25 g / g) is prepared.

[0173] (2) Dilute ethanol percolation method

[0174] 1. Weighing of medicinal materials: Chuanwu, Dahuanghua, Cynanchum chinense, Rhubarb and Phellodendron chinense are crushed and passed through a No. 2 sieve to obtain powders of each medicinal material; according to the prescription in Example 1, the above five powders are weighed.

[0175] 2. Extraction (percolation): Soak the five-flavor powder in 60 v / v% ethanol for 24 hours, and the amount of 60 v / v% ethanol is 1 volume times the total weight of the above five medicinal materials; then, continue to percolate with 60 v / v% ethanol in an amount of 8 times the total weight of the five medicinal materials (percolation rate is 9 ml / min / kg); collect the percolate.

[0176] 3. Concentration: The same concentration method as “water decoction method”.

[0177] 4. Molding: The molding method is the same as the “water decoction method”.

[0178] A high-dose sample II gel (raw drug amount of 1.0 g / g), a medium-dose sample II gel (raw drug amount of 0.5 g / g) and a low-dose sample II gel (raw drug amount of 0.25 g / g) were prepared.

[0179] (3) Acetic acid writhing test

[0180] 1. Feeding and grouping

[0181] 80 KM mice were fed adaptively for 5 days, and then the abdominal hair of the mice was removed with 8% sodium sulfide aqueous solution 12 hours before the experiment. The mice were randomly divided into 8 groups according to their weight using the block randomization method (KM mice were sorted from small to large according to weight, and after random numbers were assigned, each 10 mice formed a block, and the mice in the block were sorted according to random numbers, and the mice with the same sequence number in different blocks were in the same group), which were recorded as model group, positive drug group, sample I gel high-dose group, sample I gel medium-dose group, sample I gel low-dose group, sample II gel high-dose group, sample II gel medium-dose group and sample II gel low-dose group.

[0182] Model group: Each mouse was given a blank matrix at 0.2g / 20g (drug dose / body weight) (i.e. HEC dissolved in distilled water and stirred until it was in a gel state, with a final HEC concentration of 1.5wt%); Positive drug group: Each mouse was given Voltaren gel at 5mg / 20g; Sample I gel high-dose group: Each mouse was given a high-dose of Sample I gel at 0.2g / 20g (raw drug amount was 1.0g / g); Sample I gel medium-dose group: Each mouse was given a medium-dose of Sample I gel at 0.2g / 20g (raw drug amount was 0.5g / g); Sample Low-dose group of sample Ⅰ gel: each mouse was given a low dose of sample Ⅰ gel at 0.2g / 20g (the crude drug amount is 0.25g / g); high-dose group of sample Ⅱ gel: each mouse was given a high dose of sample Ⅱ gel at 0.2g / 20g (the crude drug amount is 1.0g / g); medium-dose group of sample Ⅱ gel: each mouse was given a medium dose of sample Ⅱ gel at 0.2g / 20g (the crude drug amount is 0.5g / g); low-dose group of sample Ⅱ gel: each mouse was given a low dose of sample Ⅱ gel at 0.2g / 20g (the crude drug amount is 0.25g / g).

[0183] 2. Twist reaction detection

[0184] Each group of mice was fixed with a homemade fixator. One hour later, each mouse was intraperitoneally injected with 0.6 v / v% acetic acid solution at 0.2 ml / 20 g (dose / body weight). The number of twisting reactions of the mice within 30 minutes was recorded (one twisting reaction was counted as the abdomen concaved, the hind limbs of the trunk extended, and the buttocks raised).

[0185] 3. Test results

[0186] The test results are shown in Table 1. There is no statistical difference between the dose groups of sample I gel and sample II gel; compared with the model group, the difference in the number of writhing times of mice in the medium and high dose groups of sample I gel and sample II gel was significantly reduced; there was no significant difference in the number of writhing times of mice in the dose groups of sample I gel and sample II gel and the positive drug group. It shows that the Weikang gel prepared by the two extraction process routes can relieve the writhing reaction of mice and relieve pain, and the efficacy is equivalent to that of the existing analgesic gel. At the same dose, the number of writhing times of mice after treatment with sample II gel is less than that of sample I gel, so the analgesic effect of sample II gel is better in comparison, indicating that the dilute ethanol percolation method is more conducive to extracting the effective analgesic components of each medicinal material.

[0187] Table 1 Effects of sample Ⅰ gel and sample Ⅱ gel on acetic acid-induced writhing reaction in mice ( n=10)

[0188]

[0189] Note: * indicates significant difference compared with the model group (P<0.05); · indicates no significant difference compared with the positive drug group (P>0.05).

[0190] (4) HPLC characteristic spectrum and index component retention rate determination

[0191] 1. Preparation of test solution

[0192] Gel test solution: accurately weigh 2.5 g of sample I gel (raw drug amount is 1.0 g / g) and sample II gel (raw drug amount is 1.0 g / g), respectively, put into a 25 ml volumetric flask, add methanol to dissolve and dilute to the scale, weigh the weight, ultrasonic (power 250 W frequency 40 kHz) for 30 minutes, cool, weigh again, make up the lost weight with methanol, shake well, filter, and take the filtrate to obtain.

[0193] Xu Changqing test solution: Accurately weigh 0.5g of Xu Changqing slices, place in a round-bottom flask, accurately add 50ml of methanol, weigh the weight, heat under reflux for 30 minutes, cool, weigh again, make up the lost weight with methanol, shake well, filter, and obtain the filtrate.

[0194] Rhubarb test solution: Accurately weigh 1.0g of rhubarb slices, place in a round-bottom flask, accurately add 50ml of methanol, weigh, heat under reflux for 1 hour, cool, weigh again, make up the lost weight with methanol, shake well, filter, and obtain the filtrate.

[0195] Phellodendron chinense test solution: Accurately weigh 1.0g of Phellodendron chinense slices, place in a round-bottom flask, accurately add 50ml of methanol, weigh the weight, heat under reflux for 30 minutes, cool, weigh again, make up the lost weight with methanol, shake well, filter, and obtain the filtrate.

[0196] 2. HPLC chromatography detection

[0197] Chromatographic conditions: Kromasil C18 (inner diameter 4.6 mm×column length 250 mm, particle size 5 μm) chromatographic column was used; acetonitrile was used as mobile phase A, 0.1 v / v% phosphoric acid solution was used as mobile phase B, and the gradient elution program was shown in Table 2; detection wavelength: 254 nm for paeonol, aloe-emodin, emodin, chrysophanol and rhein, and 284 nm for berberine hydrochloride and phellodendron hydrochloride; flow rate: 1 ml / min; column temperature: 30°C; injection volume: 10 μl.

[0198] Table 2 HPLC gradient elution program

[0199]

[0200] The results of the linearity, specificity, precision, repeatability, stability and sample recovery methodological evaluations showed that the above chromatographic conditions and methods were stable and feasible, and the test results were reliable.

[0201] The above chromatographic conditions were used to measure the gel test solution and the test solution of each medicinal material, and the retention rates of the seven index components (paeonol in Cynanchum chinense, aloe-emodin, rhein, emodin and chrysophanol in Rheum officinale, berberine hydrochloride and phellodendronine hydrochloride in Phellodendron) were calculated. The retention rate was calculated as follows: index component retention rate = index component content in gel / index component content in medicinal material*100%.

[0202] 3. Test results

[0203] The measured characteristic spectrum is as follows Figures 1-2 As shown in the figure, the types and peak areas of the index components in sample II gel are better than those in sample I gel. There are 7 common peaks between sample I gel and sample II gel, namely peaks 1, 2, 3, 5, 6, 7 and 8. The peak areas of these common peaks in sample I gel are smaller than those in sample II gel. In addition to the above common peaks, chromatographic peaks 4, 9, 10, 11, 12, 13 and 14 can also be seen in the characteristic spectrum of sample II gel. This shows that the types of effective components extracted by dilute ethanol percolation method are richer than those by water decoction method.

[0204] The retention rate determination results of the index components in sample Ⅰ gel and sample Ⅱ gel are shown in Table 3. The retention rates of the index components of the two gels are significantly different. Paeonol, aloe-emodin, rhein, emodin, chrysophanol, berberine hydrochloride and phellodendron hydrochloride are all retained in sample Ⅱ gel, with retention rates of 55.2%, 98.03%, 73.13%, 41.11%, 21.66%, 27.79% and 76.56%, respectively; while only berberine hydrochloride and phellodendron hydrochloride were detected in sample Ⅰ gel, with retention rates of only 5.40% and 27.38%, and the other five index components were not detected. This shows that the content of effective components extracted by dilute ethanol percolation method in sample Ⅱ gel is higher than that by water decoction method.

[0205] Table 3 Retention rate of index components in sample Ⅰ gel and sample Ⅱ gel

[0206]

[0207]

[0208] In summary, the characteristic peak types, peak areas and index component retention rates of Weikang gel prepared by the two extraction process routes are significantly different, and the extraction effect of dilute ethanol percolation method is significantly better than that of water decoction method. Therefore, dilute ethanol percolation method was used to prepare Weikang gel in the subsequent preparation.

[0209] 2. Factors affecting the extraction process

[0210] (1) Effect of the particle size of medicinal pieces on the percolation effect

[0211] 1. Crushing of medicinal pieces

[0212] Weigh appropriate amounts of Chuanwu decoction pieces, Dahuanghua decoction pieces, Xuchangqing decoction pieces, Dahuang decoction pieces and Huangbai decoction pieces, and grind them into coarse powder (all able to pass through No. 2 sieve, but mixed with no more than 40% of those that can pass through No. 4 sieve), medium powder (all able to pass through No. 4 sieve, but mixed with no more than 60% of those that can pass through No. 5 sieve) and fine powder (all able to pass through No. 5 sieve, and containing no less than 95% of those that can pass through No. 6 sieve).

[0213] 2. Preparation of percolate

[0214] Preparation of coarse powder percolation liquid: according to the prescription ratio, weigh 6.8g (6.8072g) of Chuanwu coarse powder, 16.8g (16.8012g) of Dahurian coarse powder, 22.5g (22.5035g) of Cynanchum chinense coarse powder, 22.5g (22.5079g) of Rhubarb coarse powder and 16.8g (16.8029g) of Phellodendron chinense coarse powder, a total of 85.4g; the percolation method is: use 60v / v% ethanol with 1 volume of the total weight of the five medicinal materials to soak all the coarse powders of the medicinal materials at room temperature for 12 hours, and then use 6 volumes of 60v / v% ethanol with 6 volumes of the total weight of the medicinal materials as solvent for percolation (percolation speed is 9ml / min / kg), collect the percolation liquid, put it in a 500ml volumetric flask, add 60v / v% ethanol to the scale, shake well, and set aside.

[0215] Preparation of medium powder percolation liquid: according to the prescription ratio, weigh 6.8g (6.8094g) of Chuanwu fine powder, 16.8g (16.8024g) of Dahurian hyssop fine powder, 22.5g (22.5047g) of Cynanchum wilfordii fine powder, 22.5g (22.5066g) of Rhubarb fine powder, and 16.8g (16.8024g) of Phellodendron chinense fine powder, totaling 85.4g; the percolation method is the same as that of the coarse powder percolation liquid.

[0216] Preparation of fine powder percolation liquid: according to the prescription ratio, weigh 6.8g (6.8094g) of Chuanwu fine powder, 16.8g (16.8024g) of Dahurian calamus fine powder, 22.5g (22.5047g) of Cynanchum wilfordii fine powder, 22.5g (22.5066g) of Rhubarb fine powder, and 16.8g (16.8024g) of Phellodendron chinense fine powder, totaling 85.4g; the percolation method is the same as that of the coarse powder percolation liquid.

[0217] 3. Determination of the paste yield

[0218] Accurately pipette 30 ml each of the coarse powder percolation liquid, medium powder percolation liquid and fine powder percolation liquid (equivalent to 5.1240 g of crude drug), place in an evaporating dish that has been dried to constant weight, evaporate to dryness in a water bath, dry to constant weight in a hot air oven at 120°C, cool in a desiccator for 30 minutes, accurately weigh, and calculate the paste rate.

[0219] 4. Determination of retention rate of index components

[0220] Preparation of percolation test solution: Accurately pipette 5 ml of coarse powder percolation solution, medium powder percolation solution and fine powder percolation solution, place two parallel portions in 10 ml volumetric flasks, add 60 v / v% ethanol to the scale, and filter through a microporous filter membrane (0.22 μm) to obtain the solution.

[0221] Accurately pipette 5 μl of the coarse powder percolation solution, 4 μl of the medium powder percolation solution and the fine powder percolation solution, and perform detection according to the "HPLC chromatography detection" method of this embodiment, and calculate the retention rates of the seven index components.

[0222] 5. Test results

[0223] Table 4 Statistical results of the paste yield of percolate with different particle sizes

[0224]

[0225] As shown in Table 4, the paste yield of fine powder slices is higher than that of coarse powder slices and medium powder slices.

[0226] Table 5 Statistical results of retention rate of percolate with different particle sizes

[0227]

[0228]

[0229] As shown in Table 5, the retention rates of most index components in medium powder and fine powder are not much different. Considering the production efficiency and cost of the percolation process, medium powder was selected as the particle size with the best percolation effect for subsequent experiments.

[0230] (2) Effects of immersion time, ethanol concentration, ethanol dosage and percolation rate on percolation effect

[0231] 1. Experimental design

[0232] On the basis of the medium powder particle size of the medicinal pieces, the paste yield and the retention rates of paeonol, chrysophanol, berberine hydrochloride and phellodendronine hydrochloride were used as evaluation indicators. Orthogonal test was used to design 9 experimental groups as shown in Table 6 for four factors, including immersion time (A, h), ethanol concentration (B, v / v%), ethanol dosage (C, times) and percolation rate (D, ml / min / kg).

[0233] Table 6 Four-factor three-level design

[0234]

[0235] 2. Preparation of test solution

[0236] According to the prescription ratio, 3.4 g of Chuanwu powder, 8.4 g of Dahurian safflower powder, 11.25 g of Cynanchum wilfordii powder, 11.25 g of Rhubarb powder and 8.4 g of Phellodendron chinense powder were weighed, totaling 42.7 g. Percolation was performed according to the "Percolation Method" in "2. Preparation of Percolation Solution" of this embodiment in combination with the experimental grouping shown in Table 7. The percolates were collected and placed in 500 ml volumetric flasks respectively. The corresponding solvent was added to the scale, shaken well, and refrigerated for later use.

[0237] Table 7 Experimental groups

[0238]

[0239] 3. Determination of the paste yield

[0240] Accurately pipette 59 ml of the percolated liquid obtained from each of the nine experimental groups (equivalent to 5.0386 g of crude drug), place it in an evaporating dish that has been dried to constant weight, evaporate it to dryness in a water bath, dry it in a hot air oven at 120°C to constant weight, cool it in a desiccator for 30 minutes, accurately weigh it, and calculate the paste rate.

[0241] 4. Determination of retention rate of index components

[0242] Preparation of test solution for the experimental group: Accurately pipette 5 ml of the percolate obtained from 9 experimental groups respectively, make 2 parallel portions, filter through a microporous filter membrane (0.22 μm), and obtain the test solution.

[0243] Accurately pipette 4 μl of the coarse powder percolation solution, 4 μl of the medium powder percolation solution and 4 μl of the fine powder percolation solution, and perform detection according to the "HPLC chromatography detection" method of this embodiment, and calculate the retention rates of the four indicator components.

[0244] 5. Test results

[0245] Table 8 Statistical results of orthogonal test

[0246]

[0247] Note: According to the preliminary tests, the extraction rate of chrysophanol in tests A1B1C1D1, A2B1C2D3 and A3B1C3D2 was too low to calculate the retention rate, so they were concentrated. 20 ml of the percolate from tests A1B1C1D1, A2B1C2D3 and A3B1C3D2 were taken respectively, and the solvent was recovered to dryness under reduced pressure. The residue was dissolved with the corresponding solvent and transferred to a 5 ml volumetric flask, and then the volume was fixed to the mark with the corresponding solvent.

[0248] According to the results in Table 8, intuitive analysis and variance analysis are performed, and the results are as follows:

[0249] The results of intuitive analysis show that, from the extreme difference, taking the paste yield rate as the investigation index, the influence order of each factor is B→C→A→D, and the differences among the levels of factors are not large; taking the retention rate of paeonol as the index, the influence order of each factor on this index is B→A→C→D; taking the retention rate of chrysophanol as the index, the influence order of each factor on this index component is B→C→D→A; taking the retention rate of berberine hydrochloride as the index, the influence order of each factor on this index component is B→C→A→D; taking the retention rate of phellodendron chinense hydrochloride as the index, the influence order of each factor on this index component is B→C→D→A.

[0250] The results of variance analysis showed that ethanol concentration was the most important factor affecting the percolation effect of paeonol, chrysophanol, berberine hydrochloride and phellodendron hydrochloride, followed by the influence of immersion time and ethanol dosage. For the percolation effect of paeonol, chrysophanol, berberine hydrochloride and phellodendron hydrochloride, the ethanol concentration level 3>level 2>level 1, so the optimal ethanol concentration was determined to be level 3 (80v / v% ethanol), the ethanol dosage level 2>level 3>level 1, so the optimal ethanol dosage was determined to be level 2 (6 times), and the immersion time level 3>level 2>level 1. Repeated tests showed that no immersion and immersion for 24h had no significant effect on the retention rate of paeonol, chrysophanol, phellodendron hydrochloride and berberine hydrochloride, so the optimal immersion time was determined to be 0h. There was no significant difference between levels 1, 2 and 3 in the percolation rate. Since a faster percolation rate is beneficial to improving production efficiency, the optimal percolation rate was determined to be 9ml / min / kg.

[0251] In summary, the percolation conditions were determined as follows: without soaking the medicinal powder, directly adding 80v / v% ethanol in an amount 6 times the total weight of the five medicinal materials for percolation, and the percolation rate was 9ml / min / kg.

[0252] (3) Effects of temperature and final volume on concentration effect

[0253] 1. Preparation of percolate

[0254] According to Prescription 1 of Example 1, weigh 6.8g (6.8072g) of Chuanwu powder, 16.8g (16.8012g) of Dahurian hyssop powder, 22.5g (22.5035g) of Cynanchum wilfordii powder, 22.5g (22.5079g) of Rhubarb powder and 16.8g (16.8029g) of Phellodendron chinense powder, totaling 85.4g.

[0255] According to the "percolation method" in "2. Preparation of percolation medicinal solution" of this embodiment, combined with the optimal percolation conditions for the optimal particle size of the medicinal slices determined in the previous step, a percolation solution is prepared.

[0256] 2. Reduced pressure concentration

[0257] According to the method of "3. Concentration" in "I. Determination of the Extraction Process Route" of this embodiment, 500 ml of the obtained percolate was concentrated under reduced pressure to a final volume of 80 ml, then transferred to a 500 ml volumetric flask, 80% ethanol was added to the scale, shaken, and the temperature was adjusted to 60°C, 70°C or 80°C; when the temperature was 70°C, the final concentrated volume was further adjusted to 40 ml or 60 ml, transferred to a 500 ml volumetric flask, 80% ethanol was added to the scale, and shaken; the concentrated solutions obtained under different concentration conditions were collected.

[0258] 3. Determination of retention rate of index components

[0259] Preparation of concentrated test solution: Accurately pipette 5 ml of the obtained concentrated solution into two parallel portions, place them in 10 ml volumetric flasks respectively, add 80 v / v% ethanol to the scale, and filter through a microporous filter membrane (0.22 μm) to obtain the solution.

[0260] Accurately pipette 3 μl of the concentrated test solution, perform detection according to the "HPLC chromatography detection" method of this embodiment, and calculate the retention rates of the four index components.

[0261] 4. Test results

[0262] Table 9 Statistical results of retention rate of each index component under different vacuum concentration conditions Paeonol

[0263]

[0264] As shown in Table 9, at the same final volume, compared with 60℃ and 80℃, the retention rates of the four index components in the product obtained by vacuum concentration at 70℃ were higher, among which chrysophanol, phellodendronine hydrochloride and berberine hydrochloride were basically not lost compared with before concentration; when vacuum concentration was performed at 70℃, compared with the final volume of 80ml, the retention rates of the four index components in the product obtained by vacuum concentration were similar when the final volume was 40ml or 60ml, among which the retention rates of phellodendronine hydrochloride and berberine hydrochloride were higher. Considering the production efficiency, the optimal vacuum concentration condition was determined to be 70℃ vacuum concentration to a final volume of 60ml, that is, an extract with a crude drug content of 1.4g / ml was obtained.

[0265] Example 3 Effect of Matrix on Weikang Gel Formation

[0266] Conventional water-soluble matrices include polyethylene glycol, carbomer, sodium alginate, sodium carboxymethyl cellulose, hydroxyethyl cellulose (HEC), etc. These matrices are easy to wash off, release drugs quickly, and are non-irritating to the skin and mucous membranes. Among them, gels prepared with carboxymethyl cellulose, polyethylene glycol, and sodium alginate as matrices generally have poor ductility, easy mildew, and scabs. The present invention selects hydroxyethyl cellulose and carbomer with relatively excellent performance as candidate matrices, and uses molding feasibility, appearance, spreadability, and viscosity as evaluation indicators to determine the matrix used to prepare Weikang gel.

[0267] 1. Preparation of gel

[0268] (1) Preparation of concentrated drug solution

[0269] 1. Weighing of medicinal materials: According to prescription 1 in Example 1, weigh 6.8 g (6.8072 g) of Chuanwu powder, 16.8 g (16.8012 g) of Dahurian hyssop powder, 22.5 g (22.5035 g) of Cynanchum wilfordii powder, 22.5 g (22.5079 g) of Rhubarb powder and 16.8 g (16.8029 g) of Phellodendron chinense powder, a total of 85.4 g.

[0270] 2. Extraction (percolation): Use 80v / v% ethanol in an amount 6 times the total weight of the above five herbs for percolation at a rate of 9ml / min / kg, and collect the percolation liquid.

[0271] 3. Concentration: Place the percolate in a 500 ml volumetric flask, add 80 v / v% ethanol to the mark, shake well, and concentrate on a rotary evaporator at 70°C and a vacuum degree of 0.08 MPa-0.09 MPa to a final volume of 60 ml to obtain an extract with a crude drug content of 1.25 g / ml.

[0272] 4. Dissolving Sodium Sulfate: Filter the extract while hot; weigh 11.2 g of Sodium Sulfate fine powder in the prescribed amount, add it to the filtrate of the extract, and obtain a concentrated medicinal solution after it is fully dissolved.

[0273] Prepare 2 portions of concentrated drug solution in parallel according to steps 1 to 4 above and set aside.

[0274] (2) Preparation of Borneol Microemulsion

[0275] Weigh 3.4 g of borneol powder in the prescription amount, add 3.4 ml of propylene glycol (as a solvent for fat-soluble borneol), fully dissolve in a magnetic stirrer (40° C., 300 r / min), add 6.7 g of polyoxyethylene 40 hydrogenated castor oil (RH-40) (as a cosolvent), 1.1 ml of isopropyl palmitate (as a surfactant) and 1.1 ml of 5 w / v% ethylparaben ethanol solution (as a preservative), stir evenly, add 3.5 ml of water while stirring, stir until clear, and obtain. Prepare 2 portions of borneol microemulsion in parallel and set aside.

[0276] (3) Gel Formation

[0277] 1. Using HEC as the matrix: weigh 1.5 g HEC, add it to 1 part of concentrated drug solution in small amounts and multiple times, place it on a magnetic stirrer and stir rapidly (600 r / min) until it is completely swollen; then add 1 part of borneol microemulsion, stir rapidly (600 r / min) while adding until it is evenly mixed, add distilled water to 100 g, continue stirring (600 r / min) until it is homogeneous, and the result is HEC gel (final HEC concentration is 1.5wt%).

[0278] 2. Using carbomer as the matrix: weigh 1.5 g of carbomer-940, add it to 20 ml of distilled water in portions, place it in a magnetic stirrer, stir it rapidly until it is evenly dispersed, let it stand to fully swell, then add 2 g of triethanolamine dropwise to make it into a gel state to obtain carbomer gel; slowly add 1 part of concentrated drug solution, stir it rapidly (600 r / min) until it is evenly mixed; then add 1 part of borneol microemulsion, stir it rapidly (600 r / min) while adding until it is evenly mixed, make up the weight to 100 g with distilled water, continue stirring (600 r / min) until it is homogeneous, and the result is obtained, which is recorded as carbomer gel.

[0279] 2. Evaluation of molding effect

[0280] (1) Evaluation method

[0281] The appearance of the two different matrix gels was observed with the naked eye, and the feasibility, appearance and spreadability of the gel were evaluated by observation. A rotational viscometer was used, and the rotor was selected according to the viscosity requirements. The temperature was 25°C and the speed was 6-60 r·min. -1 The dynamic viscosity of each gel was measured under the conditions of 40 °C and 10 °C, and each gel sample was measured 3 times.

[0282] (2) Evaluation results

[0283] like Figure 3 As shown in A, HEC gel is brown-yellow semi-solid, uniform in color, bubble-free, shiny, and can be shaped and hung on a stirring rod; Figure 3 As shown in B, carbomer gel is a brown-yellow viscous liquid that cannot be formed and cannot be hung on a stirring rod. After evaluation, HEC gel has good uniformity, fine texture, easy spreading, slight resistance, and moderate viscosity (4242.33mPa.s); HEC gel has poor uniformity, stratification, is not easy to spread, and has a thinner viscosity (1225.67mPa.s). This shows that HEC as a matrix is ​​more conducive to gel formation.

[0284] The thickening mechanism of carbomer is usually to neutralize carbomer into salt, so that the curled molecules are opened due to electrical repulsion and thickened. Therefore, carbomer gel is extremely sensitive to electrolytes, and electrolytes can reduce the viscosity of carbomer gel. However, the sodium sulfate in the Weikang gel formula has ionizable cations and quaternary ammonium cations. After experimental identification, the molding effect of carbomer gel is improved when sodium sulfate is not added, but it is still not as good as HEC gel. Therefore, HEC was determined as the matrix for preparing Weikang gel.

[0285] Example 4 Effect of transdermal penetration enhancers on the efficacy of Weikang gel

[0286] 1. Preparation of drug solution

[0287] (1) Weighing of medicinal materials

[0288] According to the prescription 1 in Example 1, 13.6 g of Chuanwu powder, 33.6 g of Dahurian dwarf powder, 45 g of Cynanchum wilfordii powder, 45 g of Rhubarb powder and 33.6 g of Phellodendron chinense powder were weighed, a total of 170.8 g.

[0289] (2) Extraction (percolation)

[0290] Use 80v / v% ethanol in an amount 6 times the total weight of the above five medicinal materials for percolation at a rate of 9ml / min / kg, and collect the percolation liquid.

[0291] (3) Concentration

[0292] The percolated liquid was placed in a 1000 ml volumetric flask, 80 v / v% ethanol was added to the mark, shaken well, and concentrated on a rotary evaporator at 70°C and a vacuum degree of -0.06 MPa to a final volume of 60 ml to obtain an extract with a crude drug content of 2.85 g / ml.

[0293] (4) Dissolution of Glauber's Salt

[0294] Filter the extract while hot; weigh 22.4 g of fine sodium sulfate powder, add it to the filtrate of the extract, and after it is fully dissolved, a concentrated medicinal solution is obtained, which is a high-dose medicinal solution (raw drug amount 2.85 g / ml).

[0295] (5) Dilution

[0296] The high-dose drug solution was diluted with water to obtain a standby drug solution for preparing a gel (raw drug amount 1 g / ml).

[0297] 2. Preparation of Weikang Gel

[0298] (1) Preparation of Borneol Microemulsion

[0299] Weigh 3.4 g of borneol powder, add 3.4 ml of propylene glycol, and fully dissolve in a magnetic stirrer (40°C, 300 r / min), add 6.7 g of polyoxyethylene 40 hydrogenated castor oil (RH-40), 1.1 ml of isopropyl palmitate and 1.1 ml of 5 w / v% ethylparaben ethanol solution, stir evenly, add 3.5 ml of water while stirring, and stir until clear.

[0300] (2) Gel Formation

[0301] Weigh 1.5g HEC, add it to the reserved drug solution (raw drug amount 1g / ml) in small amounts and multiple times, place it on a magnetic stirrer and stir rapidly (600r / min) until it is completely swollen; then add borneol microemulsion, stir rapidly (600r / min) while adding until mixed evenly, add distilled water to 100g, continue stirring (600r / min) until homogeneous, and you have the product.

[0302] 3. Determination of the receptor medium for transdermal absorption test

[0303] In the in vitro transdermal absorption test, the receiving medium simulates the body fluid under the skin and is required to meet the sink condition. The selection of the receiving medium affects the test results. In this example, the effects of normal saline, ethanol-saline (4:6) solution, PEG400-ethanol-saline (1:3:6) solution, and PEG400-ethanol-saline (2:2:6) solution as the receiving medium on the transdermal absorption of the index components in the gel were investigated.

[0304] (1) Experimental animals

[0305] Thirty-six SPF-grade KM mice, weighing 18 - 22 g, were purchased from the Guangdong Provincial Medical Experimental Animal Center [Experimental Animal Quality License Number: SCXK (Guangdong) 2022 - 0002].

[0306] (2) Preparation of excised mouse skin

[0307] The KM mice were sacrificed by cervical dislocation, and the hair on the abdominal skin was shaved off. Then, a thin layer of non-irritating depilatory ointment was applied, and the remaining hair was cleaned up. The mice were placed on a clean transparent glass plate, and the abdominal skin was separated, and the subcutaneous blood vessels, fat layer, and residues were removed. The skin was repeatedly rinsed with normal saline, and after washing, the integrity of the skin was checked to obtain intact excised mouse skin as the permeation barrier. After cutting the excised mouse skin into appropriate shapes and sizes, it was stored in a -20°C refrigerator. The test should be carried out within one week. Before the experiment, the mouse skin was thawed, and the skin should be intact and undamaged.

[0308] (3) In vitro transdermal experiment

[0309] The in vitro transdermal experiment device used the LOGAN dry heating fully automatic transdermal diffusion system SYSTEM 918 - 12. The capacity of the receiving cell was 5 ml, the diameter of the supply cell was 1.5 cm, and the effective diffusion area was 1.7671 cm 2 . During the experiment, first, the excised mouse skin was thawed in a 4°C refrigerator, then taken out and placed at room temperature. The skin should be intact and undamaged, washed with normal saline, and blotted dry with filter paper. Twelve excised mouse skins were randomly taken out, fixed at the lower end of the supply cell with the stratum corneum facing the supply cell. After exhausting the air bubbles, 0.5 g of Weikang gel was applied to the stratum corneum respectively. Normal saline, ethanol-saline (4:6) solution, PEG400-ethanol-saline (1:3:6) solution, or PEG400-ethanol-saline (2:2:6) solution was added to the diffusion cell as the receiving medium. In a 37°C constant temperature water bath, it was stirred at a constant speed of 300 r / min. 2 ml of the receiving medium was taken at 2 h, 4 h, 8 h, and 12 h of stirring respectively, and at the same time, an equal amount of the same-temperature receiving medium was added to the receiving cell and the air bubbles were removed.

[0310] The taken out receiving solution was filtered through a 0.22 μm microporous filter membrane, and the relative peak areas of the characteristic spectra of paeonol, chrysophanol and berberine hydrochloride were determined according to the "HPLC chromatography detection" method of Example 3.

[0311] Table 10 Characteristic spectrum relative peak area results of different receiving media

[0312]

[0313]

[0314] As shown in Table 10, under the same crude drug concentration (1.0 g crude drug / g), the same transdermal time (12 h) and the same injection volume (40 μl), among the 13 chromatographic peaks calibrated by the gel test solution, only two chromatographic peaks, peak 10 and peak 11, exist in the saline receiving solution. Adding different proportions of PEG400 and ethanol can promote the transdermal absorption of the components. For example, when PEG400-ethanol-saline (2:2:6) is used as the receiving medium, the number of transdermal components increases to 6, and the relative peak area sum is 0.3691; PEG400-ethanol-saline When water (1:3:6) was used as the receptor medium, 8 components were able to penetrate the skin, and the relative peak area sum was 0.6718; when ethanol-normal saline (4:6) was used as the receptor medium, 10 components were able to penetrate the skin, and the relative peak area sum increased to 1.3088. However, the ethanol content should also be considered when selecting a suitable receptor medium. Although the types of transdermal components and the relative peak area sum of ethanol-normal saline (4:6) were better than those of other groups, the high proportion of ethanol contained in it may seriously damage the physiological state of mouse skin. Therefore, PEG400-ethanol-normal saline (1:3:6) was selected as the receptor medium after comprehensive consideration.

[0315] 4. Effect of transdermal penetration enhancers on transdermal absorption

[0316] (1) Preparation of gel

[0317] According to the method in Example 3, HEC gel was prepared using carbomer as the matrix.

[0318] (2) Addition of transdermal penetration enhancers

[0319] 1wt% azone (CAS#:59227-89-3), 3wt% oleic acid (CAS#:112-80-1), 3% isopropyl myristate (IPM, CAS#:110-27-0) or 5wt% propylene glycol was used as a transdermal penetration enhancer (i.e., a penetration enhancer). 5g of HEC gel and the transdermal penetration enhancer were stirred rapidly (600r / min) in small amounts and multiple times until they were uniformly mixed. HEC gel without the penetration enhancer was used as a blank control (i.e., a blank group).

[0320] (3) In vitro transdermal test

[0321] Refer to the "in vitro transdermal experiment" in "III. Determination of the receptor medium for transdermal absorption test" of this embodiment. 0.5g of the gel containing different amounts of permeation enhancers was applied to the ex vivo mouse skin in triplicate. The supply pool was fixed on the receiving pool. A PEG400-ethanol-normal saline solution (1:3:6) was added to the receiving pool as the receptor medium. The mixture was stirred at a constant speed of 300r / min in a 37°C constant temperature water bath. 2ml of the receptor medium was taken at 2h, 4h, 8h and 12h of stirring, and an equal amount of the receptor medium at the same temperature was added to the receiving pool and the bubbles were removed. The taken receptor solution was filtered with a 0.22μm microporous filter membrane for HPLC determination.

[0322] Table 11 Relative peak area results of characteristic spectra of receiving solution containing different penetration enhancers Weikang gel

[0323]

[0324]

[0325] As shown in Table 11, under the same crude drug concentration (1.0 g crude drug / g), the same transdermal time (12 h) and the same injection volume (40 μl), the Weikang gel test solution was calibrated with a total of 13 chromatographic peaks, and a total of 6 components that can be detected through the skin, namely peaks 1, 7, 8, 9, 10 and 11; different penetration enhancers have no effect on the types of transdermal components, but the total relative peak areas of the characteristic peaks are different. The relative peak area sums of the transdermal components of the Weikang gel containing 1 wt% azone, 3 wt% oleic acid and 3 wt% isopropyl myristate are all lower than the relative peak area sums of the gels without penetration enhancers, while the relative peak area sums of the transdermal components of the 5 wt% propylene glycol gel are greater than those of the gels without penetration enhancers.

[0326] According to formula (1) and formula (2), the cumulative permeation amount (Q n ) and cumulative transdermal absorption percentage (W%):

[0327] Formula (1):

[0328] Formula (2): W=Q n *A / S;

[0329] In the above formula, C n is the drug concentration in the receptor medium measured at the nth sampling (μg / ml); V0 is the volume of the receptor pool (ml); C n-1 V is the drug concentration in the receptor medium measured at the n-1th sampling (μg / ml); i is the sampling volume (ml); A is the effective diffusion area (cm2 ); S is the mass of drug in the sample (g).

[0330] The transdermal diffusion curves were drawn with the cumulative transdermal absorption percentage of paeonol and berberine hydrochloride as the Y axis (w%) and time (h) as the X axis. Figure 4 As shown in the figure, the cumulative transdermal absorption percentage of paeonol in the Weikang gel containing 5wt% propylene glycol is higher than that in the Weikang gel containing 1wt% azone, 3wt% oleic acid and 3wt% IPM. Figure 5 As shown, the cumulative transdermal absorption percentage of berberine hydrochloride in the Weikang gel containing 3wt% IPM is higher than that in the Weikang gel containing 5wt% propylene glycol, 3wt% oleic acid and 1wt% azone.

[0331] (3) Determination of the skin retention of Weikang gel containing different penetration enhancers

[0332] After the penetration experiment, the skin was removed, the matrix was removed, and the remaining sample was washed with physiological saline, cut along the edge of the diffusion cell imprint, dried with filter paper, chopped, placed in a centrifuge tube and 5 small steel balls were added, 1 ml of methanol was added for 5 minutes of ultrasound, and centrifuged at 5000 rpm for 10 minutes. The supernatant was taken and filtered through a 0.22 μm microporous filter membrane as the sample solution. According to the "HPLC chromatography detection" method of Example 3, the injection volume was 25 μl for determination.

[0333] Table 12 Relative peak area results of Weikang gel skin retention containing different penetration enhancers

[0334]

[0335]

[0336] As shown in Table 12, under the same crude drug concentration (1.0 g crude drug / g), the same transdermal time (12 h) and the same injection volume (25 μl), the skin retention of different penetration enhancer gels can detect the 13 peaks calibrated by the above-mentioned Weikang gel test solution. The types of retained components in the skin have no significant effect, but the total relative peak areas of the characteristic peaks are different.

[0337] Calculation of skin retention of ingredients in ex vivo skin layers (Q s / μg·cm -2 ): Q S =VC / A, where A is the effective diffusion area, V is the total volume of the skin extract, and C is the mass concentration of the drug in the skin extract. The results are shown in Table 13. The skin retention amounts of different ingredients are different, among which berberine hydrochloride and paeonol are significantly higher than chrysophanol.

[0338] Table 13 Results of skin retention of index components of Weikang gel containing different penetration enhancers (n=3)

[0339]

[0340]

[0341] There are sebaceous glands, hair follicles and sweat glands in the dermis, as well as abundant capillaries, lymphatic vessels and nerves (for pain perception). Drugs enter the dermis and subcutaneous tissue through the epidermis and exert local therapeutic effects such as analgesia; drugs enter the systemic circulation through the skin microcirculation and produce systemic effects. Therefore, the skin permeability and skin retention rate of paeonol, berberine hydrochloride and chrysophanol are added as the total permeability. The results are shown in Table 14. It can be seen that different penetration enhancers have different permeation effects on each index component. Although each penetration enhancer cannot significantly increase the permeation amount of paeonol, 3wt% IPM can promote the transdermal absorption of berberine hydrochloride; the skin retention results show that 1wt% azone, 3wt% IPM and 5wt% propylene glycol can increase the retention of the index component in the skin.

[0342] Table 14 Total permeability results of gel index components containing different permeation enhancers ( n=3)

[0343]

[0344] Taking into account the total permeability of each index component, the total permeability of the gel containing 5wt% propylene glycol is higher than that of the blank group and better than that of other groups. Therefore, propylene glycol was selected as the transdermal absorption enhancer.

[0345] The effect of different concentrations of propylene glycol on the rough skin penetration of Weikon gel was further investigated. The results showed that Weikon gel containing 2wt%, 5wt% and 7wt% propylene glycol could increase the skin permeability of paeonol and berberine hydrochloride, among which the promoting effect of 5wt% propylene glycol was further superior to 2wt% and 7wt%. Therefore, 5wt% propylene glycol was determined as the optimal transdermal absorption enhancer for Weikon gel.

[0346] Example 5 Safety Evaluation of Weikang Gel

[0347] 1. Preparation of drug solution

[0348] Same as Example 4.

[0349] 2. Preparation of Weikang Gel

[0350] Same as Example 4.

[0351] 3. Preparation of blank matrix

[0352] HEC was dissolved in distilled water and stirred until it was in a gel state to obtain a blank matrix with a final HEC concentration of 1.5 wt%.

[0353] 4. Acute toxicity test for external use

[0354] (1) Feeding and grouping

[0355] Sixteen KM mice were fasted but not watered for 12 hours and weighed. The mice were randomly divided into two groups according to their body weight using the block randomization method, which were respectively recorded as the blank matrix group and the external gel group.

[0356] Blank matrix group: each mouse was given blank matrix; external gel group: each mouse was given Weikang gel (raw drug amount 1g / g). The mice were fixed with a homemade fixator and the drugs were administered to the mice twice within 12 hours.

[0357] (2) Toxicity test

[0358] After the last administration, the toxic reactions of mice in each group were observed, and the physical signs (appearance, respiration, movement, muscle tension, reflexes, eyelids, feces and skin) of the mice were monitored for abnormalities within 72 hours, and the deaths were recorded.

[0359] (3) Inspection results

[0360] After observation, the mice in the blank matrix group and the topical gel group had no abnormal signs within 72 hours of topical administration. The mortality of the two groups of mice is shown in Table 15, and the mortality rate is 0%, which is equivalent to 59 times the intended clinical dosage for adults. This shows that the Weikang gel provided by the present invention has good safety and no obvious acute toxicity for topical use.

[0361] Table 15 Record of animal deaths

[0362]

[0363] Example 6 Weikang tincture

[0364] 1. Preparation method

[0365] (1) Weighing of medicinal materials

[0366] According to prescription 1 in Example 1, 6.8 g of Chuanwu powder, 16.8 g of Dahurian dwarf lily powder, 22.5 g of Cynanchum wilfordii powder, 22.5 g of Rhubarb powder and 16.8 g of Phellodendron amurense powder were weighed, totaling 85.4 g.

[0367] (2) Extraction (percolation)

[0368] Percolation was performed with 80 v / v% ethanol in an amount of 6 times the total weight of the medicinal material at a rate of 9 ml / min / kg, and the percolation liquid (raw drug amount of about 0.17 g / ml) was collected.

[0369] (3) Add borneol

[0370] Weigh 3.4 g of borneol powder and dissolve it in the percolation solution. Add water to make the alcohol content reach 50 v / v% (determined by an alcoholometer).

[0371] (4) Dissolution of Glauber's Salt

[0372] Weigh 11.2 g of mirabilite powder, add it to the solution obtained in the previous step and fully dissolve it, then add 50 v / v% ethanol to 1000 ml to obtain (raw drug amount 0.1 g / ml).

[0373] 2. Usage and dosage

[0374] 2-3 sprays / person, 3-5 times a day, about 2 ml / person / day.

[0375] Example 7 Weikang Liniment

[0376] 1. Preparation method

[0377] (1) Weighing of medicinal materials

[0378] According to the prescription 1 in Example 1, 34g of Chuanwu powder, 84g of Dahurian dwarf vine powder, 112.5g of Cynanchum wilfordii powder, 112.5g of Rhubarb powder and 84g of Phellodendron chinense powder were weighed, a total of 427g.

[0379] (2) Extraction (percolation)

[0380] Use 80v / v% ethanol in an amount 6 times the total weight of the above five medicinal materials for percolation at a rate of 9ml / min / kg, and collect the percolation liquid (about 2000ml).

[0381] (3) Concentration

[0382] The percolate was placed on a rotary evaporator and concentrated under reduced pressure at 70°C and a vacuum degree of -0.06 MPa to a crude drug concentration of 1.0 g / ml. Ethanol was added to make the alcohol content reach 50 v / v% (determined by an alcoholometer) and set aside.

[0383] (4) Dissolution of borneol and sodium sulfate

[0384] Weigh 17g of borneol powder and dissolve it in the above concentrated solution, then add 11.2g of sodium sulfate powder. After it is fully dissolved, add 50v / v% ethanol to 1000ml, leave it overnight, filter, and you will get the raw drug (raw drug amount 0.5g / ml).

[0385] 2. Usage and dosage

[0386] 2-3 sprays / person, 3-5 times a day, about 2 ml / person / day.

[0387] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit the protection scope of the present invention. For ordinary technicians in this field, other different forms of changes or modifications can be made based on the above descriptions and ideas. It is not necessary and impossible to list all the implementation methods here. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the claims of the present invention.

Claims

1. A Chinese medicine composition, It is characterized in that The invention is prepared from the following components: by weight, 4-8 parts of Chuanwu, 14-18 parts of Dahurian Wolfberry, 20-24 parts of Cynanchum wilfordii, 20-24 parts of Rhubarb and 14-18 parts of Phellodendron amurense.

2. A Chinese herbal medicine extract, It is characterized in that It is the water extract and / or alcohol extract of the traditional Chinese medicine composition according to claim 1.

3. Use of the Chinese medicine composition according to claim 1 and / or the Chinese medicine extract according to claim 2 in the preparation of a product for treating pain.

4. An external medicine for treating pain, It is characterized in that Contains the Chinese medicine composition according to claim 1 and / or the Chinese medicine extract according to claim 2.

5. The external medicine according to claim 4, It is characterized in that The external medicine is a liquid preparation or a semisolid preparation.

6. The external medicine according to claim 5, It is characterized in that The matrix of the semisolid preparation is a water-soluble matrix.

7. The external medicine according to claim 5, It is characterized in that The semisolid formulation further comprises a transdermal penetration enhancer.

8. The external medicine according to claim 7, It is characterized in that The transdermal penetration enhancer is any one of azone, oleic acid, isopropyl myristate and propylene glycol.

9. A method for preparing an external medicine for treating pain, It is characterized in that The following steps are involved: S1. The Chinese medicine composition according to claim 1 is treated by decoction or percolation; S2. Fully mix the product obtained in step S1 with the sodium sulfate and borneol to obtain the product; the amount of the crude drug per 1 g or 1 ml of the product obtained in step S1 is 0.1 g / ml to 1.5 g / ml.

10. The preparation method according to claim 9, It is characterized in that In step S2, the method for adjusting the amount of crude drug in the product obtained in step S1 is concentration.

Citation Information

Patent Citations

  • Powder for curing pains of muscles and bones

    CN1730082A